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Abstract
Type-2 Familial Partial Lipodystrophy is caused by LMNA mutations. Patients gradually lose subcutaneous fat from the
limbs, while they accumulate adipose tissue in the face and neck. Several studies have demonstrated that autophagy is
involved in the regulation of adipocyte differentiation and the maintenance of the balance between white and brown
adipose tissue. We identified deregulation of autophagy in laminopathic preadipocytes before induction of
differentiation. Moreover, in differentiating white adipocyte precursors, we observed impairment of large lipid droplet
formation, altered regulation of adipose tissue genes, and expression of the brown adipose tissue marker UCP1.
Conversely, in lipodystrophic brown adipocyte precursors induced to differentiate, we noticed activation of autophagy,
formation of enlarged lipid droplets typical of white adipocytes, and dysregulation of brown adipose tissue genes. In
agreement with these in vitro results indicating conversion of FPLD2 brown preadipocytes toward the white lineage,
adipose tissue from FPLD2 patient neck, an area of brown adipogenesis, showed a white phenotype reminiscent of its
brown origin. Moreover, in vivo morpho-functional evaluation of fat depots in the neck area of three FPLD2 patients by
PET/CT analysis with cold stimulation showed the absence of brown adipose tissue activity. These findings highlight a
new pathogenetic mechanism leading to improper fat distribution in lamin A-linked lipodystrophies and show that
both impaired white adipocyte turnover and failure of adipose tissue browning contribute to disease.
Introduction
Lipodystrophic syndromes are rare heterogeneous
genetic diseases associated with LMNA, PPARG, BSCL2,
or other gene mutations or acquired diseases induced by
the use of some human immunodeficiency virus (HIV)
protease inhibitors1,2. These diseases are characterized by
generalized or partial fat dystrophy associated with
metabolic complications comprising severe insulin resis-
tance, diabetes, dyslipidemia, and non-alcoholic fatty liver
disease2–4.
The phenotype of nuclear envelope-linked lipodystro-
phies ranges from the typical Familial Partial Lipody-
strophy of the Dunnigan type (also called type 2 Familial
Partial Lipodystrophy, FPLD2) due to heterozygous
mutations of the LMNA gene encoding lamin A/C to
© The Author(s) 2019
OpenAccessThis article is licensedunder aCreativeCommonsAttribution 4.0 International License,whichpermits use, sharing, adaptation, distribution and reproduction
in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if
changesweremade. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to thematerial. If
material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Correspondence: Giovanna Lattanzi (giovanna.lattanzi@cnr.it)
1CNR - National Research Council of Italy, Institute of Molecular Genetics “Luigi
Luca Cavalli-Sforza”, Unit of Bologna, Bologna, Italy
2IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy
Full list of author information is available at the end of the article.
These authors contributed equally: Camilla Pellegrini, Marta Columbaro
Marta Columbaro is affiliated to the Laboratory of Musculoskeletal Cell Biology
of Istituto Ortopedico Rizzoli.


































complex diseases that can combine lipodystrophy, meta-
bolic complications, bone resorption with osteoporosis
and osteolysis, and signs of accelerated aging3,5,6.
FPLD2 (OMIM - # 151660) is a rare form of genetic
lipodystrophy with onset around puberty. The disease is
caused by the accumulation of mutated forms of lamin A
precursor (prelamin A) in patient cells5,7, leading to
altered transcription factor import5,6,8. A hotspot for
FPLD2 is codon482 of the gene (p.R482W/Q or L
mutation), although mutations can be found even in the
protein N-terminal domain. FPLD2 clinical features
include anomalous fat distribution (loss of peripheral
subcutaneous fat and abnormal accumulation of fat in the
neck and face), severe metabolic alterations with insulin
resistance, generalized dyslipidemia, and early cardiovas-
cular complications3.
Recent advances in the pathogenesis of different types of
lipodystrophy generally pointed to primary adipocyte
alterations leading to impaired adipogenesis and/or
deregulation of the adipocyte lipid droplets2. However,
the precise mechanisms linking nuclear envelope
abnormalities to lipodystrophies remain largely
unknown3. Physiological mechanisms that regulate brown
adipose tissue (BAT) or white adipose tissue (WAT)
distribution in the body have been recently addressed9,10,
and major players and rules have been identified11,12. The
adipose organ, an organ recently recognized to have
anatomical and functional features, may contain brown
and/or white adipocytes depending on the body district,
age, and environmental stimuli12. Brown adipocytes are
multilocular cells and contain high number of mito-
chondria that express uncoupling protein 1 (UCP1), a
protein that shifts mitochondrial activity toward heat
production. White adipocytes are typically cells with a
unique enlarged vacuole that stores lipids and can
undergo lipolysis when required12. Exposure to cold
increases BAT amount and activity, especially in BAT
districts, which in humans are around the major blood
vessels, the supraclavicular region, and the neck10,12.
Conversely, obesogenic conditions favor an increase of
white adipocytes in the adipose organ, mostly in sub-
cutaneous and visceral fat depots12,13. A major player in
BAT formation is adrenergic signaling, mostly mediated
by beta 3 adrenoreceptors. Indeed, BAT is highly inner-
vated by noradrenergic fibers. As a general rule, BAT
formation is mainly due to the conversion of white adi-
pocytes. In recent years, several studies have reported that
autophagy, a lysosomal degradation pathway, is involved
in the regulation of lipid metabolism and in the main-
tenance of the balance between WAT and BAT12,14,15.
Activation of autophagy is fundamental in WAT differ-
entiation by repressing the proteasome-dependent
degradation of PPARγ213 and eliciting a reduction in
mitochondrion number16 as well as activation of lipid
droplet fusion17. Autophagy is upregulated in the adipose
tissue of obese subjects. In contrast, chemical inhibition of
autophagy or knockdown of critical macroautophagy
genes (ATG7 or ATG5)17,18 led to browning of WAT,
thereby reducing lipid accumulation15.
Based on our morphological observations of FPLD2
tissue and cells, the latter showing the accumulation of
autophagic vesicles in laminopathic preadipocytes derived
from neck adipose tissue, we wondered whether an
autophagic alteration could occur in FPLD2 and influence
adipocyte determination and differentiation. Studies per-
formed by other authors in human mesenchymal stem
cells accumulating prelamin A showed altered activity of
the transcription factor Oct-1, which affected the
expression of genes in the mammalian target of rapamy-
cin (mTOR) pathway19, the main pathway of autophagic
signaling. Our experimental approach was based on the
use of brown preadipocytes from FPLD2 patient neck or
white adipocyte precursors induced to accumulate pre-
lamin A. In laminopathic adipocyte precursors, we could
determine early activation and block of autophagy. These
events were associated with impaired differentiation of
WAT precursors and differentiation of brown pre-
adipocytes toward the WAT phenotype.
Thus, we suspected an in vivo alteration of BAT activity
in FPLD2 patients. A previous study demonstrated UCP1
positivity of adipose tissue derived from the neck area of
FPLD2 patients20, supporting the hypothesis that fat from
that district, although showing a WAT appearance, could
be of brown origin. Here we confirmed that FPLD2 adi-
pose tissue from the neck is composed of an intermediate
brown–white fat that expresses molecular markers of
BAT10. Moreover, by in vivo imaging of fat distribution in
FPLD2 patients, we showed a functional failure of BAT.
The recognized method to estimate BAT activity in vivo is
the 18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) positron-
emission tomographic and computed tomographic (PET/
CT) scan with cold stimulation9,21. Previous studies have
demonstrated that in normal subjects, cold stimuli induce
browning in fat depots of the face, neck, and supraclavi-
cular regions9,22,23. The PET/CT analysis with cold sti-
mulation of three women affected by FPLD2
demonstrated the absence of active BAT depots in all
examined subjects, consistent with the observed dysre-
gulation of adipocyte differentiation. As a whole, the
biochemical, morphological, and in vivo studies reported
here are consistent with a pathogenetic hypothesis that
links unscheduled autophagic activation to altered BAT
and WAT turnover in FPLD2.
Materials and methods
Cell culture and transfection
BAT specimens were obtained from perithyroid biop-
sies of subjects undergoing surgery for benign thyroid
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disorders or from FPLD2 patients carrying the classical
FPLD2 mutations R482Q or R482W (female, mean age 30
years) undergoing aesthetic surgery in the neck and
perithyroid area, upon written consent. These samples
were used to test protein expression or to establish brown
adipocyte precursor cultures. Skin biopsies obtained from
healthy volunteers undergoing orthopedic surgery or
FPLD2 patient biopsies obtained during routine diag-
nostic protocols served for the isolation of human sub-
cutaneous fat (WAT). Individual data were handled
confidentially and anonymously according to the local and
European ethical rules.
All cell cultures belonged to the BioLaM biobank with
approval of the Rizzoli Orthopedic Institute Ethical
Committee number 0018250. Preadipocytes were seeded
in flasks and maintained in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 20% fetal calf
serum (FCS), penicillin, and streptomycin (growth
medium).
To induce prelamin A accumulation in control cells, the
non-peptidomimetic drug N-acetyl-S-farnesyl-l-cysteine
methylester (AFCMe, 10 μM) that blocks prelamin A
maturation24, thus inducing accumulation of farnesylated
prelamin A, was added to culture medium of a subset of
primary white preadipocytes.
Control white or brown preadipocytes at day 10 or 20 in
differentiation medium were transfected with wild-type
(WT) LMNA or R482QLMNA FLAG-tagged plasmids
and/or with GFP-LC3II using Amaxa Nucleofector
according to manufacturer’s instructions and published
protocols25.
To block autophagic activity, a subset of adipocytes was
treated with 25 μM chloroquine6.
White and brown adipogenic differentiation
To induce preadipocyte differentiation, white and
brown adipocyte precursors at day 2 post confluence were
shifted in induction medium composed of DMEM plus
10% FCS supplemented with 0.85 µM insulin (19278,
Sigma), 0.2 nM triiodothyronine (T3) (T-2877, Sigma),
1 µM dexamethasone (265005, CalBiochem), 0.5 mM
isobutylmethylxanthine (I-5879, Sigma) and 125 nM
indomethacin.
For white adipogenic differentiation, after 3 days of
induction, the medium was replaced by white differ-
entiation medium (WAT medium): DMEM plus 10%
FCS supplemented with 0.85 µM insulin (19278,
Sigma), 0.2 nM triiodothyronine (T3) (T-2877, Sigma),
100 nM pioglitazone (E6910, Sigma), and 125 nM
indomethacin. WAT medium was replaced every other
day and cells were allowed to differentiate for 6
additional days.
For brown adipogenic differentiation, after 3 days of
induction, the medium was replaced by brown
differentiation medium (BAT medium): DMEM plus 10%
FCS, 0.85 µM insulin, 20 nM T3, and 100 nM pioglita-
zone. Cells were maintained in BAT medium for 17 days
and the medium was replaced every other day. Twelve
hours before the end of the differentiation protocol, cells
were treated with 10 μM forskolin (F-3917, Sigma) and
1 μM pioglitazone directly added to the differentiation
medium (total days 20).
Antibodies
Antibodies employed for western blotting analysis or
immunofluorescence labeling were as follows: anti-lamin
A/C, goat polyclonal (SC-6215, Santa Cruz Biotechnol-
ogy); anti-prelamin A, goat polyclonal (SC-6214 Santa
Cruz Biotechnology); anti-prelamin A3, rabbit poly-
clonal26; PPARγ rabbit polyclonal (Cell Signaling Tech-
nology); anti-UCP1 antibody (Santa Cruz); anti-TOM20
antibody (Millipore); anti-LC3 rabbit polyclonal (NB100-
2220, Novus Biological); anti-P62/SQSTM1, guinea pig
polyclonal (GP62-C, Progen Biotechnik); anti-p70S6
kinase and anti-phospho-p70S6 kinase (Thr389) (Cell
Signaling Technology); anti-Erk 1/2 and anti-phospho
Erk1/2 (Thr202/Tyr204) (Cell Signaling Technology);
anti-actin, goat polyclonal (A1616, Santa Cruz Bio-
technology); anti-GAPDH, mouse monoclonal (MAB374,
Millipore).
Immunofluorescence
Human preadipocytes grown on glass coverslips were
fixed with absolute methanol at −20 °C for 7 min or 4%
paraformaldehyde in phosphate-buffered saline (PBS) at
room temperature for 10min. Cells fixed in paraf-
ormaldehyde were permeabilized using 0.15% Triton X-
100. After saturation of nonspecific binding with PBS
containing 4% bovine srum albumin (BSA), coverslips
were incubated with primary antibodies overnight at 4 °C
and revealed with fluorescein isothiocyanate (FITC) or
Tetramethylrhodamine (TRITC)-conjugated secondary
antibodies (1 h at room temperature). Samples were
mounted with an antifading reagent (Molecular Probes
Life Technologies) and observed with a Nikon ECLIPSE
Ni epifluorescence microscope. Images captured by NIS-
Elements 4.3 software were elaborated using Photoshop
CS. NIS-Elements 4.3 software was also used for quanti-
tative analysis of fluorescent signals.
Western blotting
Cells were lysed in buffer containing 20mM Tris-HCl,
pH 7.5, 1% SDS, 1 mM Na3VO4, 1 mM phe-
nylmethylsulfonyl fluoride, 5% β-mercaptoethanol, and
phosphatase/protease inhibitor mix (Millipore), sonicated,
and centrifuged for 30min at 4 °C. Clarified lysates were
diluted in Laemmli buffer, subjected to SDS-
polyacrylamide gel electrophoresis (6%, 8% or 4–20%
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gradient gel), and transferred to nitrocellulose membranes
(Bio-Rad) overnight at 4 °C. Membranes were saturated
with 4% BSA and incubated with primary antibodies for
1 h or overnight. Secondary antibodies were used at a
1:15,000 dilution for 20 min. Immunoblotted bands were
revealed by the Amersham ECL detection system. Inten-
sity measurements were performed using a Bio-Rad
densitometer (GS 800) equipped with Quantity One
Software.
Electron microscopy
Cell pellets from control and FPLD2 preadipocytes
were fixed with 2.5% glutaraldehyde–0.1 M cacodylate
buffer pH 7.3 for 1 h at room temperature. After post-
fixation with 1% osmium tetroxide (OsO4) in 0.1 M
sodium cacodylate buffer for 1 h, the pellets were
dehydrated in an ethanol series, infiltrated with pro-
pylene oxide and embedded in Epon resin. Ultrathin
sections (60 nm thick) were stained with uranyl acetate
and lead citrate (15 min each), and were observed at a 0°
tilt angle with a JEOL JEM-1011 transmission electron
microscope operated at 100 kV. At least 300 cells per
sample were observed.
Real-time PCR
Total RNA was extracted with TRI Reagent Solution
(Ambion) and treated with TURBO DNase (Ambion).
cDNAs were prepared using a High-Capacity RNA-to-
cDNA Kit (Applied Biosystems) according to the manu-
facturer’s protocol. Gene expression was quantified by
quantitative PCR using Power SYBR Green PCR master
mix (Applied Biosystems) and analyzed by the StepOne-
Plus Real-Time PCR System (Applied Biosystems). The
primers used in this study are reported in Table 1. Dis-
sociation curve analysis was performed to determine
target specificity. Transcript levels were normalized to the
internal standard gene GAPDH.
In vivo study
Subjects
Three unmedicated women affected by FPLD2 were
enrolled in the in vivo study and underwent the PET/CT
study with cold stimulation. Their ages were 24, 36, and
60 years, whereas their body mass index values were 22,
25, and 26 kg/m2, respectively. The diagnosis of FPLD2
was genetically confirmed. In particular, two patients were
heterozygous for R482Q, whereas one patient was het-
erozygous for R482W.
PET study protocol
On the day of the PET/CT session, participants were
studied after a fasting period of at least 4 h. A catheter was
inserted in an antecubital vein for blood withdrawal and
tracer injection. Then, subjects were exposed to a 2 h cold
preconditioning, including light clothing, room tempera-
ture of 21.3 ± 0.1 °C, and intermittent feet immersion
(5 min in/5 min out) in cold water (4 ± 1 °C). After 2 h,
subjects were transferred to the PET/CT room (21.8 ±
0.4 °C). During the PET/CT scan, a cold fan was oriented
toward the patients’ feet to maintain the cold stimulus.
Blood samples were withdrawn at baseline (before the
beginning of preconditioning), after 1 and 2 h from the
beginning of the cold test, and at the end of the PET/CT
session to measure norepinephrine and glucose levels. At
the same time points, body temperature was measured
and a Visual Analogue Scale assessing the degree of cold
perceived (0= no cold at all, 10 the highest cold I ever
perceived) was administered to the subjects.
PET scanning and image processing
PET images were acquired dynamically with a PET/CT
scanner (Discovery VCT, GE Healthcare, CT, USA). A
bolus of 195 ± 15MBq of the glucose analog 18F-2-fluoro-
2-deoxy-D-glucose (18F-FDG) was administered and a
dynamic emission scan with variable frame length (12 ×
Table 1 List of primers used in this study
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10 s, 2 × 30 s, 3 × 60 s, 2 × 120 s, 8 × 300 s) was started
simultaneously to image the neck region, from the mas-
toid process of the temporal bone (rostrally) to the cla-
vicular region (caudally). Next, a static total-body PET
image was acquired. Small blood samples were withdrawn
at 30, 40, and 50min from the beginning of the dynamic
PET acquisition to monitor glycemia.
All sinograms were corrected for deadtime, decay, and
photon attenuation, and reconstructed by standard algo-
rithms. Regions of interest (ROIs) were manually drawn in
the fusion image composed of PET and CT images in all
three transaxial, sagittal, and coronal planes to identify fat
depots in the cheek, neck, and supraclavicular regions
(density on CT between −200 and −10 Hounsfield units
compatible with CT density of adipose tissue). ROIs were
also drawn on the trapezius muscle. A small circular
region was drawn in the clavicular region corresponding
to the subclavian vessel, representing the amount of tracer
available in the circulation for organ extraction. Then,
regional tissue time activity curves were generated and
analyzed against radioactivity in blood using the Patlak
model27 to quantify the tissue extraction rate constant (Ki,
ml/min/ml). Tissue glucose uptake (µmol/100 ml/min)
was obtained by multiplying the Ki value by the mean
plasma glucose concentration during PET and expressed
per 100ml of tissue volume. We additionally calculated
the semiquantitative standardized uptake value (SUV) by
dividing tissue radioactivity in the last PET frame by the
injected dose of 18F-FDG (dose per kilogram). A maximal
SUV of 18F-FDG of at least 2.0 g/ml was considered
compatible with the presence of BAT.
Blood catecholamine measurement
To assess plasma norepinephrine levels, blood was
collected in ice with glutathione [concentration]. Then,
whole blood was centrifuged at 4 °C, plasma separated,
and norepinephrine assessed by an high-performance
liquid chromatography system (Chromsystems Instru-
ments and Chemical GmbH) according to the manu-
facturer’s instructions.
Statistical analysis
Three biological replicates per experiment were
obtained and cell cultures from three FPLD2 patients
carrying the above reported mutations were used in this
study. Data are expressed as the means of three or more
different experiments ± SD. Statistical analyses were per-
formed using GraphPad software or IBM SpSS Statistic,
Version 20.0 for MAC. Comparisons between groups
were made by Student’s t-test. Differences were con-
sidered significant for < 0.05 and highly significant for p <
0.01. A single symbol (*) indicates p < 0.05 and a double
symbol (**) indicates < 0.01.
Results
Early activation and block of autophagy in laminopathic
adipocyte precursors
Autophagy in brown adipocyte precursors
Compared with control adipose tissue from the trunk,
markers of BAT, including UCP1, type II deiodinase
(DIO2), and PR domain containing 16 (PRDM16), were
upregulated in control and FPLD2 adipose tissue from the
neck area (Fig. 1a). Based on this result, we considered
these samples to be BAT. From these tissues, we derived
primary cell cultures. PRDM16 and UCP1, markers of the
brown adipose lineage, were also positive in cultured
preadipocytes, whereas DIO2 was only expressed in dif-
ferentiated cells (Fig. 1b). Of note, PRDM16 was highly
increased in FPLD2 preadipocytes, whereas very low levels
of PRDM16 and UCP1 were detected in FPLD2 adipo-
cytes with respect to reference control cells (Fig. 1b).
Relative expression of BAT- and WAT-specific marker
genes in white vs. brown adipocytes is shown in Supple-
mentary Fig. S1.
FPLD2 preadipocyte nuclei showed typical laminopathic
morphology5,28,29, with formation of honeycomb struc-
tures at the nuclear envelope and lamin A/C and emerin
aggregates (Fig. 1c).
By ultrastructural analysis, we observed the accumula-
tion of autophagic vesicles both in FPLD2 preadipocytes
and in differentiated FPLD2 adipocytes but not in controls
(Fig. 1d). Thus, we sought to analyze the autophagic
pathway in these cells. To this end, the autophagy markers
LC3 and P62 were examined6. P62 and the LC3II form of
LC3 are known to accumulate in cells when autophagy is
activated and then blocked22. To test autophagic flux, we
used chloroquine, a known inhibitor of lysosomal activity
that causes accumulation of P62 and LC3II when added to
cells with active autophagy. Western blotting analysis
showed accumulation of LC3II in all chloroquine-treated
samples, indicating basal levels of autophagy in all cell
cultures and efficient inhibition of the autophagic flux by
chloroquine (Fig. 1e). In untreated control brown pre-
adipocytes, low levels of P62 were detected by western
blotting analysis, whereas P62 accumulated in FPLD2
preadipocytes (Fig. 1e). However, relative to the corre-
sponding untreated cells, P62 was increased in
chloroquine-treated control brown preadipocytes but not
in FPLD2 (Fig. 1e), indicating that autophagy was an
ongoing process in control cells, whereas it was impaired
in FPLD2 preadipocytes. In differentiated control adipo-
cytes, P62 accumulated and chloroquine treatment failed
to increase P62 accumulation (Fig. 1e), suggesting a block
of autophagy, as expected for brown adipogenesis. Con-
versely, low levels of P62 were detected in differentiated
FPLD2 adipocytes (Fig. 1e), which suggested active
autophagy, although the lack of P62 accumulation upon
chloroquine treatment (Fig. 1e) could indicate an aberrant
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Fig. 1 Early activation of autophagy in laminopathic brown preadipocytes. a Quantitative RT-PCR analysis of the BAT markers DIO2, PRDM16, and
UCP1 in subcutaneous adipose tissue of control subjects (control sAT) or in adipose tissue from the neck area of controls (control neck) or FPLD2 patients
(FPLD2 neck). Statistically significant differences are referred to subcutaneous adipose tissue (control sAT) values. b Quantitative RT-PCR analysis of the BAT
markers DIO2, PRDM16, and UCP1 in control or FPLD2 neck preadipocytes either non-differentiated (ND) or after 20 days of differentiation toward the
brown lineage (BAT). Statistically significant differences between values measured in control and the corresponding ND or BAT FPLD2 cells are indicated
(*). c Control and FPLD2 neck-derived preadipocytes (FPLD2) were costained for lamin A/C (green) and emerin (red), and nuclei were counterstained with
DAPI (blue). Bar, 10 μm. The percentage of nuclei with protein aggregates (lamin A/C or emerin) is reported in the graph. Data refer to 200 nuclei per
sample in three independent counts. Statistically significant differences between values measured in control and FPLD2 ND cells are indicated (*).
d Electron microscopy analysis of control (control) or FPLD2 (FPLD2) neck preadipocytes. Pictures from proliferating cells (ND) or after differentiation for
20 days (BAT), displaying mitochondria, autophagosomes (arrowheads), and autolysosomes (arrows). Bar, 1 μm in the upper panels. Bar, 100 nm in the
lower panels. The percentage of cells with autophagosomes or with more than three autolysosomes and the number of autolysosomes per cell are
reported in the upper graph. The number of autolysosomes per cell is reported in the lower graph. Fifty cells per sample were counted in three
independent experiments. Statistically significant differences between values measured in control and the corresponding ND or BAT FPLD2 cells are
indicated (*). e Western blotting analysis of prelamin A and the autophagic markers P62 and LC3 in control and FPLD2 preadipocytes (same samples as in
b). PPARalpha is shown as a marker of differentiation. GAPDH bands are shown as protein loading controls. Molecular weight markers are reported in kDa.
Densitometric analysis of immunoblotted prelamin A, lamin A, PPARG alpha, P62, and LC3II bands is reported in the graphs. Statistically significant
differences between values measured in untreated and chloroquine-treated cells are indicated (*). f Immunofluorescence analysis of P62 (green) and LC3
(red) in control and FPLD2 preadipocytes (same samples as in b). DNA was stained with DAPI (blue). Statistical analysis of the number of P62 and LC3
puncta is reported in the graphs. Bar, 10 μm. Statistically significant differences between values measured in control and the corresponding ND or BAT
FPLD2 cells are indicated (*). g GFP-LC3II and FLAG-LA staining in control BAT adipocytes expressing LA-WT or LA-R482Q. Statistical analysis of the number
of cells with GFP-LC3II puncta is reported in the graph. Statistically significant differences between values measured in LA-WT and the corresponding LA-
R482 cells are indicated (*). h Western blotting analysis of mTOR, p-mTOR, p70S6k, and p-p70S6K in control (control) and two different FPLD2 patient ND
cell cultures (FPLD2). Tubulin bands are shown as protein-loading controls. Densitometry of phosphorylated proteins is reported in the graph. When
comparing wild-type and FPLD2 samples, three biological replicates were used in each experiment as well as in qRT-PCR analyses. Statistically significant
differences between values measured in control and FPLD2 cells are indicated (*)
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autophagic process. Consistent with these results,
immunofluorescence analysis showed the presence of
P62- and LC3-labeled vesicles in undifferentiated FPLD2
cells but not in controls, whereas P62 and LC3 puncta
were almost undetectable in differentiated cells (Fig. 1f).
Cotransfection of control adipocytes at day 20 in differ-
entiation medium with LA-WT or LA-R482Q and GFP-
LC3II was also performed to test autophagic activity.
Processing of GFP-LC3II in transfected cells was tested by
western blotting analysis, which showed cleavage and
degradation of green fluorescent protein (GFP) in cells
that did not express lamin A constructs and a sharp
cleavage band corresponding to GFP in LA-WT and LA-
R482Q cotransfected cells (Supplementary Fig. S2). These
results suggested a reduced processing rate in LA-WT
and LA-R482Q-expressing cells, because the GFP band
was accumulated but not degraded30. GFP-LC3II puncta
were detectable in LA-WT-transfected BAT adipocytes
and their number was slightly but not significantly
increased upon chloroquine treatment, indicating low
autophagic activity (Fig. 1g). However, the number of
GFP-LC3II puncta was significantly increased in LA-
R482Q-expressing cells upon chloroquine inhibition of
lysosomal activity, thus demonstrating active autophagy
(Fig. 1g)30.Thus, although autophagy was detectable in
control preadipocytes and was inhibited upon brown
differentiation, as expected, our data indicated (1)
autophagy induction and simultaneous block in undif-
ferentiated laminopathic BAT precursors and (2) mod-
erate autophagy activation in differentiating FPLD2
brown preadipocytes25.
These data were suggestive of defective autophagic
signaling in FPLD2 preadipocytes and adipocytes. In
agreement with this hypothesis, western blotting analysis
showed unaffected levels of mTOR phosphorylation but
increased phosphorylation of p70S6 kinase in FPLD2 cells
(Fig. 1h). mTOR-independent activation of p70S6 kinase
had been previously reported31,32 and will be discussed in
this paper.
Autophagy in white adipocyte precursors
Then, we sought to analyze autophagy in WAT-derived
pre-adipocytes. FPLD2 WAT-derived preadipocytes
showed typical laminopathic nuclear morphology, lamin
A/C and emerin aggregates, and prelamin A accumulation
(Fig. 2a). Markers of WAT, including adiponectin (ADI-
POq gene), GLUT4, and leptin, were analyzed in control
and FPLD2 cells (Fig. 2b). Adiponectin and GLUT4
mRNA were expressed in all examined samples, with an
increased level of adiponectin mRNA in FPLD2 pre-
adipocytes (Fig. 2b). Notably, both ADIPOq and GLUT4
mRNA expression was increased upon differentiation of
control but not FPLD2 cells (Fig. 2b). Leptin expression
was almost undetectable in controls, although a slightly
increased level was determined in FPLD2 preadipocytes
(Fig. 2b). However, the expression of leptin mRNA was
increased in differentiated control cells, whereas it was
decreased in FPLD2 adipocytes relative to the corre-
sponding undifferentiated cells (Fig. 2b). Relative expres-
sion of brown and white adipocyte-specific marker genes
in a comparison of in vitro differentiated white vs. brown
adipocytes in parallel is shown in Supplementary Fig. S1.
As we failed to obtain a sufficient number of cells from
FPLD2 WAT biopsies, we decided to mimic the condition
of FPLD2 WAT-derived preadipocytes that accumulate
prelamin A5,7,33–35. To this end, a subset of control white
preadipocytes from subcutaneous tissue (here referred to
as sAT cells) was treated with AFCMe. Thereafter, we
refer to AFCMe-treated preadipocytes as A-sAT cells.
In undifferentiated and differentiated sAT cells, P62 and
LC3II levels were increased upon chloroquine treatment
(Fig. 2c), indicating active autophagy36,37. These results
were expected, as autophagic flux has been associated
with white adipogenesis15. However, in chloroquine-
treated undifferentiated A-sAT cells, LC3II levels, but
not P62 levels, were increased (Fig. 2c). These results
suggested autophagic activation and block36. However,
P62 levels were increased in chloroquine-treated A-
sAT cells, indicating some induction of the autophagic
process in differentiated laminopathic cells (Fig. 2c).
Nevertheless, although P62-LC3-labeled autophagic vesi-
cles were hardly detectable in sAT cells (Fig. 2d), as
expected during active autophagy, all A-sAT cells showed
a high number of autophagic vesicles labeled by both
markers (Fig. 2d), suggestive of autophagic flux activation
and block. The study of autophagic activity performed by
cotransfection of wild-type or R482Q LMNA and GFP-
LC3II plasmids in control WAT adipocytes showed
accumulation of GFP-LC3II puncta in chloroquine-
treated cells expressing wild-type LMNA but not in
chloroquine-treated cells expressing R482Q LMNA (Fig.
2e).This result indicated inhibition of autophagic activity
in cells expressing the FPLD2 LMNA mutation. Further-
more, ultrastructural analysis showed that the percentage
of cells with more than three autolysosomes was increased
in A-sAT cells under any experimental condition (Fig. 2f).
This quantitative analysis indicated a block of autophagic
fluxin laminopathic WAT preadipocytes36.
To start addressing the mechanism that elicits early
autophagic activation and block in laminopathic WAT
preadipocytes, we evaluated the mTOR pathway in s-AT
cells expressing the FPLD2-linked R482Q LMNA. The
P62 increase observed in differentiating mutant cells
with respect to cells expressing wild-type lamin A sup-
ported the notion that autophagic activation and block
occurs in laminopathic white adipocyte precursors
(Supplementary Fig. S3,a). Notably, R482W LMNA38
expression induced phosphorylation of p70S6 kinase
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(Supplementary Fig. S3,b and c), as also observed in
FPLD2 BAT precursors (Fig. 1h). Moreover, in R482W
LMNA mutant cells, phosphorylation of Erk 1/2 (Thr389)
was increased relative to WT LMNA-expressing cells
(Supplementary Fig. S3,c). Activation of Erk 1/2 has also
been detected in models of muscular laminopathies39,40.
Notably, p70S6 kinase phosphorylation can also occur
downstream of Erk 1/2 activation41. Overall, these data
suggest that the normal autophagic process is impaired in
undifferentiated laminopathic cells, possibly due to dys-
regulation of p70S6 kinase.
Altered adipogenic differentiation in laminopathic cells
Differentiation of brown adipocyte precursors
Then, we tested the differentiation potential of lami-
nopathic adipocyte precursors. The differentiation rate of
FPLD2 neck preadipocytes induced toward the brown
lineage was significantly higher than that observed in
control cultures, as determined by the number of cells
forming lipid droplets (Fig. 3a). However, quantitative
analysis in living cells and ultrastructural analysis showed
the formation of enlarged lipid droplets in differentiating
FPLD2 preadipocytes (Fig. 3b). Furthermore, we observed
reduced expression of PPARG, but not UCP1, in cycling
FPLD2 preadipocytes and reduced UCP1 levels in differ-
entiated FPLD2 adipocytes (Fig. 3c). In the same FPLD2
cell cultures, although DIO2 expression level was com-
parable to controls, PRDM16 was increased in pre-
adipocytes and reduced in differentiated adipocytes
(Fig. 3c). Notably, at the protein level, PPARγ was not
apparently affected (Fig. 3d). This discrepancy was prob-
ably due to the higher number of differentiated adipocytes
obtained in FPLD2 cell cultures. Notably, PPARγ1 was
undetectable in FPLD2 neck preadipocytes (Fig. 3d). To
support data showing the conversion of brown
preadipocytes toward the white lineage in FPLD2, we
tested the expression of WAT markers. Relative expres-
sion of leptin and GLUT4 mRNA was slightly increased in
FPLD2 preadipocytes and adipocytes with respect to
control brown adipocytes, whereas adiponectin expres-
sion was decreased (Fig. 3e).
Differentiation of white adipocyte precursors
The data reported in Fig. 4 provide insights into the
differentiation potential of laminopathic white pre-
adipocytes. A reduced differentiation rate was measured
in A-sAT cells (Fig. 4a). Quantitative analysis of lipid
droplet diameter in living cells (Fig. 4a) and ultra-
structural analysis (Fig. 4b) allowed us to state that
dimensions of lipid droplets formed in differentiating A-
sAT cells were reduced. Moreover, A-sAT cells showed
dramatically increased PPARγ1 mRNA levels before the
onset of differentiation, whereas levels of PPARγ2 and
UCP1 mRNA were comparable to controls (Fig. 4c and
d). Nevertheless, the UCP1 protein level was increased
in A-sAT cells, possibly due to a posttranscriptional
effect. Consistent with the observed increase of UCP1, a
mitochondrion membrane component, increased levels
of TOM20, a protein located at the surface of the
mitochondrion outer membrane, were measured in A-
sAT cells (Fig. 4e). Moreover, a higher number of
mitochondria per cell was observed in laminopathic
preadipocytes (Fig. 4e). As a whole, these data indicated
that A-sATs cells had been directed toward a brown
differentiation program. In support of this observation,
we found that in FPLD2 white adipocytes, the WAT
genes ADIPOq and GLUT442 were dysregulated, as
shown above (Fig. 1b), and the BAT gene DIO2 was
upregulated (Fig. 4f).
(see figure on previous page)
Fig. 2 Early activation and block of autophagy in laminopathic white preadipocytes. a Control and FPLD2 cultured preadipocytes from
subcutaneous tissue were costained for lamin A/C (green) and emerin (red) or prelamin A (green) and PPARγ (red). Bar, 10 μm. b Quantitative RT-PCR
analysis of mRNA levels of WAT markers ADIPOq, GLUT4, and leptin in control or FPLD2 white preadipocytes, either non-differentiated (ND) or after
9 days of differentiation in WAT medium (WAT). Statistically significant differences between values measured in control and the corresponding ND or
WAT FPLD2 cells are indicated (*). A significant decrease in leptin values in WAT FPLD2 vs. ND FPLD2 is also indicated (*). c Control cultured
preadipocytes left untreated (sAT) or treated with AFCMe (A-sAT) were examined for autophagic markers. Western blotting analysis of prelamin A,
P62, and LC3 (LC3I and LC3II forms) in sAT and A-sAT cells under basal conditions (ND) or differentiated in WAT medium for 9 days (WAT). GAPDH
bands are shown as protein-loading controls. Molecular weight markers are reported in kDa. Densitometric analysis of immunoblotted prelamin A,
P62, and LC3II bands is reported in the graphs. Statistically significant differences between values measured in untreated and the corresponding
chloroquine-treated cells are indicated (*). d Immunofluorescence detection of P62 (green) and LC3 (red) in sAT and A-sAT cells under basal
conditions (ND) or differentiated in WAT medium for 9 days (WAT). DNA was stained with DAPI (blue). Statistical analysis of the number of P62 and
LC3 puncta is reported in the graphs. Statistically significant differences between values measured in sAT and the corresponding A-sAT cells are
indicated (*). Bar, 10 μm. e GFP-LC3II and FLAG-LA staining in control WAT adipocytes expressing wild-type LMNA or R482Q-LMNA. Statistical analysis
of the number of cells with GFP-LC3II puncta is reported in the graph. Fifty cells showing FLAG staining of the nuclear lamina were examined per
sample. Statistically significant differences between values measured in wild-type LMNA and the corresponding R482-LMNA cells are indicated (*).
f Electron microscopy analysis of sAT and A-sAT cells under basal conditions (ND) or after 9 days in WAT medium (WAT). Arrowheads:
autophagosomes; arrows: autolysosomes. Bar, 1 μm. The percentage of cells with more than three autophagosomes/autolysosomes is reported in the
graph. Fifty cells per sample were counted in three independent experiments. Three biological replicates were used in each experiment as well as in
qRT-PCR analyses. Statistically significant differences between values measured in sAT and the corresponding A-sAT cells are indicated (*)
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Adipose tissue from the FPLD2 neck district shows an
intermediate brown/white phenotype and the absence of
BAT activity
In agreement with the results obtained in cultured cells,
FPLD2 neck adipose tissue showed an intermediate
brown–white fat phenotype, as observed by electron
microscopy analysis (Fig. 5). Although control adipose
tissue from the neck area showed a number of small lipid
droplets (diameter: 10–100 μm), FPLD2 adipose tissue
appeared mostly formed by large lipid droplets (diameter:
Fig. 3 (See legend on next page.)
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100–200 μm or more), typical of subcutaneous WAT
(Fig. 5a). As expected, we detected prelamin A (Fig. 5b)
and UCP1 proteins (Fig. 5c) in adipose tissue from the
FPLD2 patient neck and, interestingly, the absence of
PPARγ1 (Fig. 5c), as observed in cultured preadipocytes
(Fig. 3d). Thus, we concluded that the R482W lamin A
mutation affects BAT features in the neck area. The
in vivo study performed in FPLD2 patients strongly sup-
ported these findings, as reported below.
Cold exposure of healthy subjects induces activation of
BAT in specific depots, where BAT is detectable by 18F-2-
fluoro-2-deoxy-D-glucose (18F-FDG) uptake threefold
higher than the other adipose tissue depots23. In cold-
exposed healthy subjects, uptake values of 18F-FDG of at
least 2.0 μmol/100 ml/min are considered compatible
with the presence of BAT. Cold-induced fat 18F-FDG
uptake values in several regions of the face and neck, and
in the supraclavicular regions of FPLD2 patients are
shown in Fig. 5d, e, together with the 18F-FDG uptake
measured in skeletal muscle in the same conditions.
The18F-FDG uptake in the upper and lower cheek regions
was 1.34 ± 0.22 and 1.34 ± 0.14 μmol/100 ml/min,
respectively, whereas the fat depot in the chin showed
lower values of 0.39 ± 0.02 μmol/100 ml/min. In the neck,
we identified by CT two lateral fat depots, one placed
more externally (outer) and the other more internally
(inner), and two dorsal fat depots, one placed in the upper
and the other in the lower half of the neck. Their cold-
induced 18F-FDG uptake values were 1.33 ± 0.42, 1.40 ±
0.23, 1.16 ± 0.36, and 0.81 ± 0.30 μmol/100 ml/min,
respectively. At the supraclavicular level, medial and lat-
eral fat depots had cold-induced 18F-FDG uptake of
0.60 ± 0.25 and 0.58 ± 0.28 μmol/100 ml/min, respectively.
Overall, the mean value of cold-induced 18F-FDG uptake
in all adipose depots was 1.00 ± 0.42 μmol/100 ml/min.
Skeletal muscle 18F-FDG uptake during the cold test was
0.70 ± 0.05 μmol/100 ml/min. We also calculated the
SUVs in each region. As expected, 18F-FDG uptake values
were correlated with SUVs (r= 0.620, p < 0.002), which
had a mean value of 0.46 ± 0.22 g/ml in the fat of the face
region, 0.50 ± 0.15 g/ml in the neck and 0.37 ± 0.14 g/ml
in the fat of the supraclavicular region. These values were
incompatible with BAT, which has a described SUV of
18F-FDG of at least 2.0 g/ml43,44. During cold exposure of
FPLD2 patients, skin body temperature and glycemia did
not significantly change, whereas plasma norepinephrine
levels increased by twofold (p= 0.05) and were consistent
with the scoring of subjects’ own cold perception
(Table 2).
Discussion
The study reported here shows that autophagy plays a
role in the pathogenetic pathway of FPLD2 by altering the
fate of adipogenic precursors. The first finding of our
study is that early activation of autophagy occurs in
undifferentiated laminopathic adipocyte precursors, but
the autophagic flux does not proceed properly in those
cells. How lamin A mutations and/or prelamin A accu-
mulation interferes with autophagic pathways is in part
explained by data reported by Infante, showing that an
aberrant interaction between prelamin A and the tran-
scription factor Oct-1 elicits mTOR inhibition and
autophagy19. We previously reported sequestration of
Oct-1 at the nuclear envelope in Mandibuloacral Dys-
plasia6, another LMNA-linked disease featuring partial
lipodystrophy. Here we observed slightly reduced mTOR
phosphorylation in laminopathic cells, as expected when
autophagy was induced6,45. Nevertheless, hyperpho-
sphorylation of p70S6 kinase, a downstream effector of
mTOR signaling, was detected in FPLD2 preadipocytes.
Thus, our data suggest mTOR-independent phosphor-
ylation of p70S6 kinase in FPLD2 cells, a mechanism
previously reported31,32,46, which deserves further inves-
tigation. Although the effect of mTOR-independent
p70S6K activation on the autophagic process is still elu-
sive, indirect evidence of a role in autophagic block is
provided by a recent study performed in Lmna-null mice,
a model of muscular laminopathies. The authors showed
(see figure on previous page)
Fig. 3 Altered differentiation of laminopathic BAT precursors. a Differentiation rate of control and FPLD2 BAT precursors is shown in the upper
graph. The number of cells with lipid droplets observed by phase-contrast microscopy is reported. Lipid droplet diameter frequency in control and
FPLD2 BAT adipocytes at day 9 of differentiation is shown in the lower graph. Data are the percentage of total counted vesicles (300 per sample in
three different samples). b Representative images of cultured control and FPLD2 living cells at day 9 during BAT differentiation (phase-contrast living
cells) and electron microscopy images of the same cell culture (electron microscopy). L, lipid droplet; m, mitochondrion. Bars, 10 μm for phase-
contrast pictures, 1 μm for electron microscopy. c Quantification of PPARG, UCP1, DIO2, and PRDM16 expression by qRT-PCR in control and FPLD2 cells
under basal conditions (ND) or after 20 days of differentiation toward the brown lineage (BAT). Statistically significant differences between control
and the corresponding FPLD2 cells are indicated (*). d Western blotting and densitometric analysis of PPARγ in control and FPLD2 adipocyte
precursors under basal conditions (ND) or after 20 days of differentiation (BAT). The actin band is shown as a loading control. Western blotting and
densitometric analysis of PPARγ isoforms in isolated control and FPLD2 adipocyte (BAT) nuclei is shown on the right. C-EBPα bands were stained as
loading controls, indicating comparable amounts of adipocytes. Molecular weight markers are reported in kDa. e Quantitative RT-PCR analysis of WAT
markers leptin, GLUT4, and ADIPOq in control or FPLD2 brown adipocyte precursors. Three biological replicates were used in each experiment as well
as in qRT-PCR analyses. Data are means of three independent experiments ± SD. Statistically significant differences (p < 0.05) between control and
corresponding FPLD2 samples are indicated (*)
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that partial knockout of p70S6k is sufficient to extend
lifespan in knockout animals featuring autophagy
impairment and premature death47.
Here we showed that FPLD2-linked LMNA mutations
cause both p70S6K activation and Erk1/2 hyperpho-
sphorylation, a defect previously associated with Mandi-
buloacral Dysplasia48 and well described in laminopathic
muscle39 featuring autophagic impairment49. The differ-
ent involvement of mTOR, p70S6K, and/or Erk1/2 in
diverse laminopathic tissues40 could be relevant to the
onset of disease symptoms. In this respect, the increase in
phosphorylated Erk 1/2 in cells bearing FPLD2 or
MADA-linked LMNA mutations, but not in cells bearing
a mutation linked to progeria (with generalized lipoa-
trophy)48, could suggest different mechanisms that war-
rant investigation.
Under physiological conditions, degradation of PPARγ 2
proteases and fusion of lipid vesicles are the result of
autophagic processes that occur during WAT differ-
entiation and favor PPARγ 2 stabilization and formation
of large lipid storage droplets13. In laminopathic pre-
cursors, we showed that autophagy is inhibited during
white adipogenesis. Thus, reduced lipid vesicle fusion
could be a consequence of impaired autophagy. In
agreement with our results, the accumulation of autop-
hagic markers in the absence of any lysosome inhibitor
was recently reported in white preadipocytes derived from
FPLD2-induced pluripotent stem cells50. In contrast, the
autophagic process is not inhibited in differentiating BAT
preadipocytes. In these cells, the formation of enlarged
lipid droplets is the most likely consequence of aberrant
autophagy, a process that does not take part in normal
BAT development. Interestingly, although we could
detect autophagic activity in brown adipocytes coexpres-
sing GFP-LC3II and FPLD2-mutated LMNA, we also
observed some accumulation of autophagosomes at the
nuclear lamina in those cells, indicating that lamin A itself
is targeted for lysosomal degradation.
In fact, lamin B51 and mutated lamin A6,52,53 may
undergo autophagic degradation. As we previously
observed autophagic degradation of prelamin A in MADA
cells5, we cannot exclude the possibility that autophagic
block could contribute to prelamin A accumulation in
FPLD2 preadipocytes. Our present data showing autop-
hagic impairment in FPLD2 do not allow us to determine
whether A-type lamins are targeted for degradation.
As a whole, a complex network of defective signals is
elicited by altered lamin A. In laminopathic WAT pre-
cursors, we observed upregulation of the γ1 isoform
PPARG and increased protein levels. Dysregulated
expression of PPARG before the onset of differentiation
likely contributes to impaired WAT differentiation54, as
previously shown in cells featuring an altered lamina55.
Recently, PPARγ2 was shown to have a positive correla-
tion with fat depot formation, whereas PPARγ1 has a
negative correlation56. Although we did not observe any
effect on PPARγ2 mRNA expression in our experimental
model of laminopathic WAT, we have previously reported
significantly reduced PPARγ2 mRNA levels in the thigh of
FPLD2 patients, one of the most lipodystrophic districts33.
Other depot-specific genes are also affected in lamino-
pathic WAT precursors, supporting the hypothesis of an
aberrant conversion of white preadipocytes towards the
brown lineage. In fact, ADIPOq and GLUT4 induction is
significantly reduced in differentiating white FPLD2 adi-
pocytes, whereas the BAT-specific gene DIO2 is upregu-
lated. Moreover, we observed increased levels of UCP1
protein in laminopathic WAT precursors. The expression
of thermogenic genes has been associated with the for-
mation of brite or beige adipocytes and the reduction of
adipose tissue in obese animals57. However, recent studies
have proposed a mixed phenotype of the adipose organ,
which can potentially activate BAT or increase WAT
depending on environmental stimuli57. Knockdown of the
PPARG gene has been shown to induce both UCP1
expression and gain of a brown-like phenotype in WAT
precursors58. However, we did not observe a transcrip-
tional effect on the UCP1 gene, suggesting that the
observed increase in protein levels could be due to post-
translational mechanisms or could be related to the
(see figure on previous page)
Fig. 4 Altered differentiation of laminopathic WAT precursors. a Differentiation rate of control (sAT) and laminopathic WAT precursors (A-sAT) is
shown in the upper graph. Lipid droplet diameter frequency in sAT and A-sAT adipocytes at day 9 of differentiation. Data are percentage of total
counted vesicles (300 per sample in three different samples). b Representative images of cultured sAT and A-sAT living cells at day 9 in WAT medium
(phase-contrast living cells) and electron microscopy images are shown (electron microscopy). L, lipid droplets. Bars, 10 μm for phase-contrast
pictures, 1 μm for electron microscopy. c Quantification of PPARγ1, PPARγ2, and UCP1 mRNA expression by qRT-PCR in sAT and A-sAT cells under
basal conditions (ND) or exposed to WAT differentiation medium for 9 days (WAT). d Western blotting, and densitometric analysis ofPPARγ1, PPARγ2
and UCP1 in sAT and A-sAT cells under basal conditions (ND) or exposed to WAT differentiation medium for 9 days (WAT). The actin band is shown as
a protein loading control. e Western blotting and densitometric analysis of TOM20 in sAT and A-sAT cells under basal conditions (ND) or exposed to
WAT differentiation medium for 9 days (WAT). The actin band is shown as a protein loading control. The number of mitochondria per cell in the
corresponding samples as measured by electron microscopy analysis is reported in the right graph. f Quantitative RT-PCR analysis of BAT markers
DIO2, PRDM16, and UCP1 in control or FPLD2 white adipocyte precursors. Three biological replicates were used in each experiment as well as in qRT-
PCR analyses. Data are means of three independent experiments ± SD. Molecular weight markers in d and e are reported in kDa. Statistically
significant differences (p < 0.05) between control and corresponding FPLD2 samples are indicated by an asterisk (*)
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increased mitochondrion number. As a whole, both
FPLD2 adipocytes and cells accumulating prelamin A
showed features of brown preadipocytes during differ-
entiation toward the white lineage. However, the data
reported here showing impaired proliferation and differ-
entiation of these cells indicate that acquisition of such an
intermediate white/brown phenotype ultimately impairs
WAT development. Although the ratio of adipogenic
precursors in the bioptic material and in the stromal
vascular fraction could also affect adipogenic differentia-
tion in cell cultures, a reduced differentiation ability of
FPLD2 adipose tissue precursors toward the white lineage
is strongly suggested by the reported data.
In FPLD2 BAT precursors, reduced PPARG expression
in differentiated cells is in agreement with previously
reported transcriptional impairment5,33,59, although the
unaffected protein levels could be related to either
increased differentiation rate or stabilization of the pro-
tein. Importantly, the observed loss of PPARγ1 expression
could favor pathological accumulation of fat in the neck
district, as PPARγ1 downregulation has been found in
WAT depots from obese subjects60, whereas PPARγ1
activity has been linked to catabolic pathways in adipo-
cytes56. In agreement with the hypothesis of a reduced
formation of BAT in the neck of FPLD2 patients,
expression of the BAT marker PRDM16 was aberrantly
elevated in preadipocytes and significantly decreased in
FPLD2 adipocytes. In addition, UCP1 expression levels
were reduced in FPLD2 neck adipocytes. These
observations pave the way to a better understanding of the
mechanism that specifically causes the accumulation of
fat in the neck area in FPLD2 and possibly other lipody-
strophies featuring the same phenotypic abnormality.
Notably, the accumulation of fat in the neck area also
occurs in FPLD3, a disease linked to PPARG mutations1.
In addition to molecules identified in this study, other
factors, both local and systemic, might contribute to
altered autophagy and/or adipocyte differentiation in
FPLD2. For instance, the reported deregulation of cyto-
kine secretion patterns most likely affects adipogenesis in
Mandibuloacral dysplasia48, a lipodystrophic laminopathy,
and further studies are needed to determine the potential
pathogenetic effects of deregulated cytokines inFPLD2.
In conclusion, this study suggests that the pathogenetic
mechanism leading to subcutaneous WAT loss in FPLD2
is related to early activation of autophagy in adipocyte
precursors followed by autophagic flux impairment and is
associated with altered regulation of PPARγ1 and UCP1.
Conversely, the mechanism leading to fat accumulation in
the FPLD2 neck district is related to early autophagic
activation, PPARγ1 downregulation, and aberrant differ-
entiation toward the white lineage. A puzzling result of
our study is that the same LMNA mutations differentially
affect gene expression and protein regulation in WAT or
BAT. Although we cannot provide here an explanation for
this effect, we suggest that differentially expressed PPARγ
regulators54 as well as differentially expressed nuclear
envelope partners of lamin A61 may be involved.
(see figure on previous page)
Fig. 5 Neck FPLD2 adipose tissue shows an intermediate brown/white phenotype and absence of BAT activity. Characterization of adipose
tissue isolated from the neck district of healthy donors (control neck), subcutaneous tissue from the leg of healthy donors (control subcutaneous),
and FPLD2 patients neck (FPLD2 neck) is shown in a–c. a Electron microscopy analysis of control and FPLD2 adipose tissue. Small lipid droplets fusing
to a large droplet are indicated by double arrows. Bar, 2 μm. The mean adipocyte area is reported in the graph. Statistically significant differences
relative to control neck tissue are indicated (*). b Western blot analysis of prelamin A and lamin A/C in control and FPLD2 adipose tissue, and
densitometric analysis. Statistically significant differences between control and FPLD2 tissue samples are indicated (*). c Western blotting analysis of
PPARγ and UCP1 in control and FPLD2 adipose tissue and densitometric analysis. Statistically significant differences between control and FPLD2
tissue samples are indicated (*). In b and c: actin band is shown as a protein-loading control; molecular weight markers are reported in kDa. Cold-
induced fat 18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) uptake in the supraclavicular regions, face, neck, and skeletal muscle of FPLD2 patients is shown
in d, e. d Representative CT and CT-PET images referring to one out of three examined FPLD2 patients are shown. e Levels of cold-induced glucose
uptake (18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) uptake) in fat depots of the face, neck supraclavicular regions, and trapezius muscle (skeletal
muscle) of FPLD2 patients. Data are means ± SD
Table 2 Clinical parameters of FPLD2 patients subjected to cold exposure with reference values








Body temperature (°C) 36.0–37.0 36.3 ± 0.5 36.1 ± 0.3 36.0 ± 0.4 36.2 ± 0.3
Glycemia (mg/dl) 70–110 90 ± 4 89 ± 10 96 ± 8 101 ± 13
Plasma norephinephrine (nmol/l) < 4.0 3.7 ± 1.2 − 13.3 ± 10.3 7.1 ± 1.5*
VAS score (range) 0–3 0–3 8–9** 10** 7–8**
VAS, Visual Analogue Scale of thermal sensation and comfort
*p < 0.05 vs. baseline, **p < 0.01 vs. baseline
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